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ABSTRACT: Preferential crystallization is a cost eﬃcient method to
provide pure enantiomers from a racemic mixture of a conglomerate
forming system. Exploiting small amounts of pure crystals of both
enantiomers, several batch or continuous processes were developed,
capable of providing both species. However, an intermediate production
step has to be used when pure enantiomers are not available. In such
cases, partially selective synthesis, chromatography, or crystallization
processes utilizing chiral auxiliaries have to be used to provide the initial
seed material. Recently, it was shown that a coupled Preferential
Crystallization-selective Dissolution process (CPCD) in two coupled
crystallizers can be applied if at least one pure enantiomer is available to
produce both antipodes within one batch. The corresponding process is
carried out in one reactor (crystallization tank) by seeding a racemic
supersaturated solution with the available enantiomer at a certain temperature. The second reactor (dissolution tank) contains a
saturated racemic suspension at a higher temperature. Both reactors are coupled via the ﬂuid phase, allowing for a selective
dissolution of the preferentially crystallizing enantiomer from the solid racemic feed provided in the dissolution vessel. The
dissolution and crystallization processes continue until the solid racemic material is completely resolved and becomes
enantiopure. At this point, both enantiomers can be harvested in their pure crystalline form. For a speciﬁc pharmaceutically
relevant case study, a rational process design and the applied empirical optimization procedure will be described. The achieved
productivities after optimization show the great potential of this approach also for industrial applications. Also, a strategy to
control this process based on inline turbidity measurement will be presented.
1. INTRODUCTION
Enantiomers are molecules that are mirror images of each
other (optical isomers) with the same molecular structure and
identical physicochemical properties. The stereoisomerism of
two enantiomers can cause diﬀerent eﬀects if they are applied
to biological systems due to chirality of enzymes, hormones,
etc. Nowadays, there is evidence that commonly only one
enantiomer induces the desired eﬀect while the other is
inactive or even harmful.1,2 Thus, if chiral components are
utilized as a racemic mixture (50/50 ratio of both
enantiomers), half of the applied material can be toxic, cause
stress for the biological system, or is wasted leading to
environmental pollution.
The development of processes to produce pure enantiomers
is therefore a prerequisite for economically and ecologically
eﬀective applications of chiral substances in, e.g., the
pharmaceutical, food, and agrochemical industries. Even
though a direct synthesis of one single stereoisomer is
preferred, it is often expensive or impossible.3 Alternatively,
the substances can be conventionally produced as racemic
mixtures and separated subsequently with appropriate
techniques exploiting chromatography, membranes, or, like in
the present study, preferential crystallization.3−5
In order to make use of preferential crystallization, beside
the basic requirement that the racemate to be separated forms
a conglomerate, a suitable amount of homochiral crystals is
initially necessary to gain reasonable yield and productivity.
The availability of pure enantiomers can be a bottleneck. In
this study, only a very limited amount of one enantiomer of
guaifenesin was available from a complex asymmetric syn-
thesis.6 Additionally, not much was known regarding
crystallization kinetics and also solubility data were insuﬃcient.
An innovative approach is studied in this article to produce
material for further investigations that would circumvent
possible loss or contamination of the valuable starting material,
which can be a result of unknown thermodynamic or kinetic
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information. The process is based on a preferential
crystallization of only one pure enantiomer combined with
its selective dissolution from a solid mixture of racemic
composition utilizing two diﬀerent tanks, which are coupled via
the liquid phase.7,8 Below we will designate this “Coupled
Preferential Crystallization with selective Dissolution Process”
as CPCD. It is ideally suited to safely amplify a small amount
of starting material while additionally gaining access to the
counter-enantiomer in the form of crystals.
1.1. Process Principle. The process is carried out in two
tanks that are initially ﬁlled with saturated solutions of racemic
composition (xi,0, Figure 1) at one speciﬁc temperature (Tsat,
Figure 1). Solid racemic feed is provided in excess in the ﬁrst
tank, which remains at saturation temperature Tsat and serves
as the subsequent dissolution stage (dissolution tank in Figure
1 a). The second tank (crystallization tank in Figure 1a) is
cooled to a speciﬁc temperature Tcryst, where an appropriate
driving force for crystallization can be expected (ΔT = Tsat −
Tcryst), but primary nucleation does not occur. Afterward, the
separation is initiated in this crystallization tank by adding a
small amount of pure crystals of one enantiomer (here (R)).
These crystals will start to grow due to the present
supersaturation and, thereby, selectively remove the seeded
enantiomer from the liquid phase indicated by its decreasing
concentration in the mother liquor. The (R)-depleted liquid
phase is continuously transported to the dissolution tank that
is still kept at the higher saturation temperature Tsat. As a
result, the seeded (R)-enantiomer becomes undersaturated in
the dissolution vessel, which leads to its selective dissolution
from the present racemic solid phase (changing solid phase
composition in the dissolution tank, Figure 1b), thus restoring
the saturation concentration at Tsat. By coupling both reactors
via their liquid phases, the mother liquors in both vessels
remain at racemic composition if the exchange and the
dissolution processes are fast enough to counterbalance the
selective concentration decrease by the preferential crystal-
lization.
The situation right after seeding is reﬂected in the left
ternary phase diagram in Figure 1b. Initially, only a small,
enantiopure solid fraction is present in a supersaturated
racemic liquid phase at Tcryst, while, in the dissolution tank, a
large amount of racemic solid phase is in equilibrium with a
Figure 1. (a) Schematic representation of the initial situation after seeding and the separation result of the Coupled Preferential Crystallization-
Dissolution process (CPCD). (b) Representation of the composition evolution by means of a ternary phase diagram depicting the state changes in
the dissolution and crystallization tank for the ideal separation process. Right after seeding (t = tseed, left ﬁgure) only a small amount of the solid
(R)-enantiomer is present in the crystallization tank while the dissolution tank contains a large amount of crystalline racemic mixture. Afterward (t
> tseed, right ﬁgure), the mass of pure, solid (R)-enantiomer increases due to the preferential crystallization and the overall state in this vessel moves
toward the pure phase corner. Selective dissolution of the (R)-enantiomer in the dissolution tank yields a decrease of the overall crystal fraction in
suspension and an enrichment of the (S)-enantiomer in the solid phase, which moves the solid state composition in this tank to the pure (S)-phase
corner.
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racemic liquid phase saturated at Tsat. In the ideal case, the
seeded enantiomer is preferentially crystallized and primary
nucleation of the antipode is eﬃciently prevented, which
results only in an increasing solid mass in the crystallization
tank while the liquid phase composition stays racemic
(composition xi,0, Figure 1b). This is depicted in the right
ternary phase diagram in Figure 1b, where the liquid and solid
composition in the crystallization tank is constant, while the
overall state (reﬂecting the ratio between the masses of the
liquid and solid phase) moves toward the corner of the pure
(R)-enantiomer. By contrast, the solid mass decreases in the
other tank due to the selective dissolution that changes
simultaneously the enantiomeric ratio in the present crystal
phase. Hence, the solid state (right phase diagram in Figure
1b) of the dissolution tank moves toward the pure (S)-
enantiomer and the changing overall state reﬂects the loss of
solid content. Also, in this tank, the liquid phase is of racemic
composition if the selective dissolution counterbalances the
preferential crystallization and the exchange rate between both
vessels is suﬃciently high.
The process ends after the seeded enantiomer is completely
dissolved from the racemic excess material in the dissolution
tank (Figure 1a). If the process is interrupted at exactly this
time, only the seeded enantiomer is present as solid in the
crystallizer, while, in the dissolution tank, only the unseeded
enantiomer as solid is left. Further crystallization leads to an
enrichment of the unseeded enantiomer in the crystallization
tank and, similarly, to conventional preferential crystallization,
which increases the risk of primary nucleation.
1.2. Separation Problem. The API guaifenesin (3-(2-
methoxyphenoxy)-propane-1,2-diol (Figure 2) was chosen as
model substance to demonstrate the strength of this process
strategy given such a diﬃcult initial situation (small amount of
enantiopure seed material of only one antipode, little
knowledge about the substance system). Racemic guaifenesin
is widely applied as an antitussive with an expectorant and
decongestant eﬀect. Nevertheless, the substance is also a
valuable precursor for other pharmaceuticals like muscle
relaxants (methocarbamol9), tranquilizers (mephenoxalone9),
and β-blockers (levomoprolol6) that are partly used in
enantiopure form in therapy. Some of the latter substances
form “true” racemates (racemic compounds) and are therefore
not suitable for a direct and eﬀective resolution via preferential
crystallization without previous treatment. Guaifenesin, on the
contrary, forms a stable conglomerate in water, and a
procedure to access the pure enantiomers batchwise from
enriched and racemic solutions was already reported.6,10
2. EXPERIMENTAL SECTION
2.1. Substance System. Racemic guaifenesin was purchased from
TCI Deutschland GmbH (purity > 98%) and used without further
treatment. Water as solvent for the separation experiments and the
washing procedure was deionized with a milli-Q system (Merck
Millipore, Milli-Q Advantage).
Pure (R)-guaifenesin was provided by the Arbuzov Institute of
Organic and Physical Chemistry (Prof. Alexander A. Bredikhin,
Russian Academy of Sciences, Kazan) with a total mass of 0.8 g.
Guaifenesin dissolved in water is known to form a conglomerate10
without occurrence of solvates or other polymorphs over the
temperature and composition range of interest. It crystallizes in an
orthorhombic crystal lattice11 (space group P212121) with a needle-
like habit of the macroscopic particles (Figure 3a).
Solubility data of the racemic mixture and the (R)-enantiomer
measured with a polythermal method10 and utilized for the design of
the ﬁrst experiment are shown in Figure 3b. The solubilities of both
the racemic mixture and the pure enantiomer show a strong nonideal
and nonlinear behavior, rather two lines with a bend in between,
indicating a potential phase change. However, during this study (ref
10), only the known polymorph was found and hydrate formation was
not detected. Though, the occurrence of a second liquid phase, i.e., a
stable or metastable liquid−liquid demixing, was indicated.10 Other
physical properties of the substance system are listed in Table 1.
Figure 2. Chemical structure of (R)-guaifenesin.
Figure 3. (a) Microscopic image of pure (R)-guaifenesin after recrystallization. (b) Solubility of racemic (black and red squares) and (R)-
guaifenesin (blue squares) taken from ref 10 in water in comparison to the ideal solubility curve calculated according to Schröder−van Laar (black
solid line). Dashed lines are just guides for the eye.
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2.2. Basic Thermodynamic and Kinetic Investigations.
Isothermal solubility measurements and small-scale cooling crystal-
lizations of the racemic guaifenesin were carried out to complement
the data from ref 10 and to verify the evidence of a potentially
occurring second liquid phase.
15 mL portions of a suspension of water and racemic guaifenesin
were prepared for each temperature to investigate the solubility
behavior. Each vial was sealed and equipped with a magnetic stirrer
for mixing. All samples were then placed in thermostated double-
walled glass tanks and were initially heated to dissolve the solid phase
completely. The samples were recrystallized subsequently by cooling
to the temperature of interest and left for equilibration (t > 48 h).
Afterward, 2−3 mL of liquid phase was withdrawn, weighed, and
placed in a vacuum oven for drying. The mass of the residual solid
phase eventually yielded the solubility at the respective temperature.
At least three diﬀerent samples were prepared for each temperature
step (temperature range 5−50 °C), where a part of the clear liquid
phase of each sample was collected at least two times for
concentration analysis.
To investigate the metastable zone width and additionally the
occurring phases, a multireactor system was utilized (Crystalline,
Technobis Crystallization Systems). This measurement system
enables polythermal experiments with overhead stirring and
observation of the samples by camera and light scattering. Samples
were prepared in 6 mL glass vials for seven diﬀerent concentrations
corresponding to saturation temperatures between 28 and 43 °C. The
vials were subsequently cooled linearly until the lowest possible
temperature was reached (−20 °C) or when a turbidity drop
indicated the occurrence of a solid phase. Altogether, ﬁve diﬀerent
cooling rates were investigated ranging from −0.5 to −80 K/h. Image
data around the identiﬁed nucleation points were inspected afterward
with respect to the occurring phase and to possibly correct the
turbidity measurement. All prepared concentrations were measured
5−20 times for each cooling rate (except for −0.5 K/h, where only 2
measurements were possible).
2.3. Experimental Setup for Resolution Trials. All separation
experiments applying the CPCD process were carried out in two 450
mL double-walled crystallizers (Figure 4) equipped with Teﬂon
coated propeller type stirrers (stirrer motor: Heidolph, RZR 2102
control) and thermostats for temperature control (Lauda, Proline RP
845). Both tanks are connected to a bypass for online analyses, which
consist of a polarimeter (IBZ Messtechnik, POLARmonitor) and a
measurement of the total concentration. Two diﬀerent properties,
density (Mettler Toledo, DE40) and UV absorption (KNAUER, UV-
Detector K-2501), were investigated for concentration analysis since
no appropriate process online measurement for the considered
concentration range of guaifenesin is reported up to now. Both loops
are fed with a crystal-free liquid phase by peristaltic pumps (Heidolph,
PD 5201 SP Quick) at a rate of 3.5 mL/min.
The mother liquor exchange during the actual experiments was
carried out by gear pumps (Tuthill, D-Series, V̇ = 0−30 mL/min)
connected to mass-ﬂow controllers (Bronkhorst Maettig GmbH, mini
Cori-Flow M14), which enable a precise volume control in both tanks
as well as a measure of temperature and density of the present liquid
phase. All tubes are heated slightly above saturation temperature via
thermostats (Lauda, Ecoline RE 104, Julabo, FS 18) to prevent
Table 1. Physical Properties of Solid Racemic Guaifenesin
and a Saturated Solution at 36°C
solid state properties (safety data sheet12)
molar mass 198.22 g/mol
melting point 78−83 °C
boiling point 215 °C
density 1.2 g/cm3
solid state properties from own measurements
melting pointa 78.6 °C
enthalpy of fusiona 191.4 J/g
densityb 1.25 g/cm3




aMeasured via DSC (Setaram, DSC 131). bMeasured via volume
expansion of a saturated solution by addition of a deﬁned solid mass.
cMeasured via densitometry (Mettler Toledo, DE40).
Figure 4. Coupled dissolution/crystallization plant consisting of two double-walled 450 mL tanks, two online analytic bypasses, and two liquid
exchange sections. Frit - ﬁlter frit; M - stirrer motor; MFM - mass-ﬂow meter; T - Pt100; Turb. - turbidity probe.
Crystal Growth & Design Article
DOI: 10.1021/acs.cgd.8b01660
Cryst. Growth Des. 2019, 19, 3148−3157
3151
blockage. The dissolution tank is additionally equipped with a
turbidity probe (Mettler Toledo, Trb. 8300) to follow the decrease in
suspension density. Pt100 sensors were used to measure the
temperatures of each vessel and of the solution bypassed for online
analyses.
2.4. HPLC Analysis. Samples of the crystalline products at the end
of each experiment were investigated by HPLC with respect to purity
and composition. A Chiralcel-OD-H (4.6 × 250 mm, particle size 5
μm) column was utilized with an Agilent 1200 system (Agilent
Technologies) and 65/35 n-hexane/isopropanol as eluent. Flow rate,
UV wavelength, column temperature, and injection volume were 1
mL/min, 275 nm, 23 °C, and 5 μL, respectively.
2.5. XRPD Analysis. The solid products were investigated with an
X’Pert Pro Diﬀractometer (PANalytical GmbH) using Cu Kα
radiation and an X’Celerator detector in the 2θ range of 3−40°
with a step size of 0.017° and a step time of 50 s per step.
No phase change was observed during the investigations, and
always anhydrous guaifenesin was crystallized.
2.6. Experimental Procedure Development. The initial testing
experiment is shown in Figures 5 and 6. A major challenge was to ﬁnd
suitable analytics to track the evolution of the liquid phase
composition as well as the expected reduction in racemic suspension
density in the dissolution tank caused by the selective removal of (R)-
guaifenesin. In earlier studies on, e.g., threonine,7 a combination of
density and optical rotation angle (ORA) measurement had proven as
reliable techniques for process monitoring. However, it was not
possible to follow the process trend by these measurement techniques
alone due to the low speciﬁc ORA of guaifenesin and only slight liquid
density changes during crystallization. A semipreparative UV detector
was therefore additionally used in the crystallization tank, providing a
better resolution of concentration changes.
CPCD is a quasi-steady-state process, and hence, no changes in the
liquid phase composition are expected as long as process conditions
are chosen appropriately. Nevertheless, the process needs to be
interrupted when the provided solid material in the dissolution tank
becomes enantiopure to prevent nucleation in the crystallization tank
and to ensure maximal yields. The process equals afterward a
preferential crystallization characterized by a decreasing concentration
and no further removal of the initially racemic solid excess material in
the dissolution tank. Hence, inline turbidity measurement was utilized
in this tank to monitor and control the process. It is able to indicate
the quantitative selective dissolution of the crystallizing enantiomer
and the process end by reaching a lower plateau.
Figure 5 shows the preparation phase of the ﬁrst experiment. On
the basis of initial solubility data,10 solutions in both reactors were
prepared to be saturated at 35 °C. The saturation point was chosen to
avoid an eventual liquid−liquid demixing but enabling crystallization
at moderate temperatures over a wide range of supersaturations (see
Figure 3b). Five standards of racemic guaifenesin were added to the
crystallization tank for calibration, which is indicated by the stepwise
increase of the UV signal (Figure 5, right). Both tanks were kept at 45
°C during this period to ensure complete dissolution of the feed
material.
After cooling of both tanks to saturation temperature, at t ≈ 1.7 h,
20 g of solid racemate to be separated was added to the dissolution
tank, resulting in a strong increase of the turbidity signal (Figure 5,
left). Liquid exchange was subsequently turned on at a rate of 5 mL/
min to equilibrate the solutions in both tanks. Unexpectedly, the
added material dissolved quickly, which was detected by the decrease
in turbidity (black line, dissolution tank, Figure 5, left) and the further
increase of the UV signal at t ≈ 2 h (black line, crystallization tank,
Figure 5, right). With a diﬀerent process strategy (e.g., conventional
Figure 5. Startup-phase and UV calibration during the trial experiment (Tsat = 35 °C, Tcryst = 30−34 °C, Exp. 1 in Table 3). Outliers or peaks in the
UV and ORA signals in the crystallization tank originate from measured air bubbles, which is also valid for the following process trajectories shown
(Figures 6, 9, and 10).
Figure 6. Dissolution and crystallization phase of the trial experiment after start-up and calibration shown in Figure 5 (Tsat = 35 °C, Tcryst = 30−34
°C, Exp. 1 in Table 3).
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PC or coupled PC13), the obvious inaccuracy of the solubility data
would have been left undetected and a loss of the pure seed material
would have been the result. An additional 50 g of racemate was added
to the dissolution tank (t ≈ 2.8 h), which was estimated to result in a
suspension. The stabilization of the turbidity signal after ≈3.7 h
indicated that no further dissolution took place. Nevertheless, both
tanks were left overnight, exchanging mother liquor at a rate of 5 mL/
min to ensure saturation of the liquid phases. Samples were
withdrawn and analyzed gravimetrically to determine the actual liquid
phase concentration before restarting the plant.
After subcooling the solution in the crystallization tank by 0.5 K,
0.1 g of (R)-guaifenesin seeds was added to initiate the preferential
crystallization process (black dashed line, crystallization tank, Figure
6, right).
Subsequently, temperature was decreased stepwise to identify
suitable crystallization conditions. However, no signiﬁcant changes in
the signals were observed even at 30 °C (supersaturation with respect
to the racemic composition Srac = 2.16). The suspension of the
crystallization tank was ﬁnally harvested at t = 26.9 h, ﬁltered, and
carefully washed with ice-cold water. Altogether, 0.8 g of (R)-
guaifenesin was entrained with a purity of 98.52%, proving the general
feasibility of the process utilizing these conditions. However, the
amount of solid racemic excess material in the dissolution tank was
too high to be puriﬁed successfully. It was therefore reduced in
subsequent experiments. Additionally, it was evident that guaifenesin
growth kinetics are rather slow. In order to improve the overall
process performance, the initial seed loading was also adapted to
provide a larger crystallization surface area.
The experimental conditions were found applicable during the trial
experiment (Table 2), which served as a starting point for further
separation runs.
3. EXPERIMENTAL RESULTS
3.1. Solubility and Metastable Zone Width. In the
preliminary experiment, deviations from the polythermal
solubility data obtained in ref 10 were observed. Hence,
additional isothermal solubility measurements were carried out
following the procedure described in section 2.2. Especially in
the range of the steep increase of the saturation curve between
30 and 45 °C, samples were prepared for temperature steps of
1 K. Even though solid phases were dissolved before
equilibration at a higher temperature, a solid phase recrystal-
lized at the respective saturation temperature. Hence, no
evidence was found supporting a stable liquid−liquid phase
separation.
The measured saturation concentrations are depicted in
Figure 7 (black crosses and dashed line), which show a similar
trend as the data from ref 10 (black and red squares for
polythermal and isothermal data, respectively). Although the
few isothermal data points from ref 10 perfectly agree, the
solubility curve is slightly shifted toward lower temperatures
compared to results of polythermal studies reported in ref 10,
which explains the unexpected dissolution during the trial
experiment. Particularly, in the range of the steepest slope of
the solubility curve, deviations of around 20 wt % occur. The
diﬀerences are probably caused by the very slow dissolution
kinetics of guaifenesin, which inﬂuences the accuracy of the
polythermal method, even though low heating ramps of 0.05
K/min were utilized in ref 10. Also, no other than the known
solid state form was found by XRPD analyses. The isothermal
solubility results from all samples are listed in the Supporting
Information (Table A1) together with the standard deviations
of samples of one particular temperature.
Metastable zone widths were investigated for diﬀerent
concentrations with a polythermal method and are shown in
Figure 8. As expected, the metastable zone width increases
with increasing cooling rate. Further, it can be seen that, for
high cooling rates (−80 and −20 K/h), no correlation between
nucleation points and the shape of the solubility curve is
present. This can be explained by the crystallization of water
and guaifenesin together, i.e., crystallization below the eutectic
temperature, which is calculated to −4 °C from the
intersection of the liquidus lines according to the Schröder−
van Laar equation. This explanation is supported by two
diﬀerent solid phases, which were observed inside the samples
right after nucleation. For cooling rates between −0.5 and −5
K/h, the metastable zone widths, or the supersolubility curves,
follow the trend of the solubility curve with possible
subcoolings of the clear solutions ranging from 10 to 23 K
(−0.5 K/h) to 30−40 K (−5 K/h).
The recorded image data during nucleation revealed that
crystals were formed directly from the clear solutions and no
second liquid phase was observed. Thus, the hypothesis that a
metastable miscibility gap is the reason for the unusual
solubility behavior cannot be supported by this data.
3.2. Separation Results. The results of all separation
experiments, including Exp. 1 described before, are compiled in







mgua (rac.) 53.3 g
Srac 2.16 -
mseed,R 0.1−1.1 g
msol.rac.feed (dissolution tank) 3.5−40 g
V̇exchange 5−30 mL/min
Figure 7. Measured solubility curve of racemic guaifenesin
(isothermal method) in comparison with data from ref 10 and the
ideal solubility line calculated according to the Schröder−van Laar
equation. The dashed line is just a guide for the eye.
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Table 3. The essential initial parameters, the mass of seed
material, mseed, and solid racemic feed, msol.feed, are listed
together with the masses of produced solid phases in the
crystallization and dissolution tank, mR and mS. After HPLC
analysis of the crystalline products, purity in both tanks, PurR
and PurS, was determined according to eq A1 (see Supporting
Information). The listed productivities, PrR and PrS, were
calculated according to eq A2 (see Supporting Information).
The process time, tproc, was deﬁned as the time between
seeding the process and harvesting the product.
It can be seen from Table 3 that, in the ﬁrst four experiments
(Exps. 1−4), the mass of the solid racemic excess material,
msol.feed, was adapted to achieve a complete separation and,
hence, pure enantiomers in both tanks. With the process
conditions listed in Table 2, 3.5 g of solid racemic feed was
puriﬁed (Exp. 4 in Table 3) and 1.8 g of (R)- and 1.2 g of (S)-
guaifenesin with purities > 95% could be harvested. The initial
seed, mseed, and racemic solid excess masses, msol.feed, were
increased, subsequent to this successful separation, to enhance
yield and productivity of the process (Exps. 5−7). In the
following experiments (Exps. 8−10), both enantiomers of
guaifenesin were produced with high purities for further
studies. In the last experiment (Exp. 11), the technical limit of
the plant was investigated. An initial racemic solid excess mass
was chosen, which allowed just for an appropriate liquid phase
exchange with respect to ﬁlter blocking and exchange rate
(technical limit 30 mL/min).
The online measurements of the ﬁrst successful separation
(Figure 9; Exp. 4, see Table 3) show similar trends compared
to the trial experiment following the preparation procedure
(dashed lines at t = 0 h in Figure 9). The stable UV signal
indicates constant concentration in both tanks (black line,
crystallization tank, Figure 9, right). The small increase of the
optical rotation signal between t = 0−6 h (blue dotted line,
crystallization tank, Figure 9, right) shows a slight enrichment
of the unseeded enantiomer in the liquid phase. Hence, the
chosen liquid phase exchange rate of 10 mL/min was almost
suﬃcient to counterbalance selective crystallization in the
crystallization tank. After seeding (dashed line in Figure 9), the
turbidity in the dissolution tank remains constant for almost 2
h, indicating an initially slow preferential crystallization caused
by the low seed loading. The signal starts to decrease
signiﬁcantly at t ≈ 2 h due to distinct selective dissolution in
this tank and subsequently reaches a plateau (t ≈ 5 h). Both
enantiomers could have been harvested at this point already
with high purity. However, to enhance productivity and yield,
the temperature in the dissolution tank was lowered to the
crystallization temperature as well, which transfers the CPCD
process into a coupled preferential crystallization.13 Hence,
both solid phases crystallize further and selectively remove the
respective enantiomer from the liquid phase. This is indicated
by a slight increase in turbidity showing that the process can in
fact be monitored reliably with this method. Afterward, both
products were withdrawn, ﬁltered, and washed.
Seed mass and solid racemic excess material were increased
stepwise for the following experiments to further enhance
productivity. Figure 10 shows experiment 11 (compare Table
Figure 8. Identiﬁed nucleation points of solutions with diﬀerent
guaifenesin concentrations, which were linearly cooled at diﬀerent
rates (0.5−80 K/h). Dashed and dotted lines are guides for the eye
for the solubility curve and the supersolubility curves at various
cooling rates, respectively.
Table 3. Product Purities, PurR and PurS, and Masses, mR and mS (Dry Product), as Well as Process Times, tproc, and
Productivities, PrR and PrS, of All CPCD Experiments Performed
a
Exp. mseed [g] msol.feed [g] mR [g] PurR [%] mS [g] PurS [%] tproc [h] PrR [g/(kg h)] PrS [g/(kg h)]
1 0.1 (37) 0.8 99 4.3 0.36
2 0.1 20 1.4 98 6.3 0.45
3 0.1 4 2.4 97 0.6 91 7.2 0.68 0.17
4 0.1 3.5 1.8 98 1.2 95 6.7 0.55 0.37
5 0.3 10 4.3 98 3.5 97 5.8 1.49 1.26
6 1.1 20 19.6 80 11.2 98 3.5 9.31 6.63
7 1.1 30 13.8 97 8.8 98 1.9 14.27 9.39
8 1.1 30 31.6 69 8.9 98 3.3 14.03 5.47
9 1.1 30 11.3 98 14.5 98 2.7 9.05 10.89
10 1.1 30 16.1 93 14.9 98 4.0 7.67 7.55
11 1.1 40 32.7 97 16.9 98 4.0 16.86 9.13
aSeeding was always done with (R)-guaifenesin except for Exp. 9, where the (S)-enantiomer was used.
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3) where 40 g of racemic guaifenesin was separated. The larger
mass of carefully ground seeds decreased the initial startup
period to 1 h and the overall process time until a complete
puriﬁcation was achieved after 4 h. A liquid exchange rate of 30
mL/min between both tanks was necessary to keep the mother
liquor at racemic composition in this case. A slight decrease of
the UV signal can be seen in the last 0.5 h (black line in Figure
10, crystallization tank, right) due to the preferential
crystallization of both enantiomers from the liquid phase at
the end of the experiment, which ﬁts well with the ﬁnal
increase in turbidity in the dissolution tank. In total, 33 g of
(R)- and 17 g of (S)-guaifenesin were produced with purities >
97%. The high productivities, which were achieved (PrR ≈ 17
g/(kg·h); PrS ≈ 9 g/(kg·h)), show the great potential of the
CPCD process also for industrial applications.
The empirical process control strategy based on the utilized
measurement techniques can be summarized as follows. If the
turbidity signal reaches a lower plateau and all other signals are
almost constant, the process can be interrupted since the
seeded enantiomer is completely removed from the solid
excess material in the dissolution tank. An accelerating
decrease of this signal without any plateau indicates primary
nucleation of the unseeded enantiomer in the crystallization
tank, followed by complete loss of the solid phase in the
dissolution stage. In this case, the seed mass or the driving
force needs to be lowered to reduce the rate of selective
entrainment in the crystallization tank. In the opposite case, if
the turbidity signal stays constant, supersaturation and seed
loading have to be increased to enhance process performance.
A change of the optical rotation or the UV absorption in the
crystallization stage indicates the selective depletion of the
seeded enantiomer from the mother liquor, increasing the risk
of primary nucleation of the antipode. The liquid exchange rate
between both tanks needs to be increased in this case, to
counterbalance the entrainment by selective dissolution.
It can be seen from the purities in Table 3 that primary
nucleation of the counter-enantiomer cannot always be
prevented in the crystallization tank. If the process is optimized
and higher supersaturations are utilized, the probability of
nucleation of the antipode increases rapidly. This is caused by
the inherently given nonrobustness of the preferential
crystallization process. A successful separation is still possible
even if nucleation of the unseeded enantiomer occurs in the
crystallization tank. In this case, the crystallization tank should
become the dissolution tank and vice versa until the nucleated
crystals are dissolved again. However, this requires a precise
analysis of the solid phase composition in each tank.
Nevertheless, below a certain supersaturation, no nucleation
will occur in a ﬁnite time but at the expense of process
performance with respect to yield and productivity. In this
case, a change of the setup could be beneﬁcial if, for example, a
wet-milling process is introduced to generate more crystal
surface and, hence, increase the productivity even at low
supersaturations.
By contrast, primary nucleation is completely avoided in the
dissolution tank; thus pure product will always be gained in
this vessel if crystallization is carried out for a suﬃciently long
duration.
Only a part of the product here can be lost if the unseeded
enantiomer nucleates in the crystallization tank. Hence, the
process needs to be adapted to every substance system,
speciﬁcally utilizing appropriate models or control strategies
like the aforementioned empirical control to achieve the
highest productivities and still meet the purity constraints in
both vessels.
Figure 9. Trajectories of turbidity, optical rotation (optical rotation angle, ORA), UV absorption, and temperature of CPCD experiment 4 (Tsat =
35 °C, Tcryst = 30 °C, Exp. 4 in Table 3).
Figure 10. Trajectories of turbidity, optical rotation (optical rotation angle, ORA), UV absorption, and temperature of CPCD experiment 11 (Tsat
= 35 °C, Tcryst = 30 °C, Exp. 11 in Table 3).
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4. CONCLUSIONS
The study has shown that the presented CPCD process is
capable of eﬃciently resolving racemic guaifenesin, providing
both enantiomers simultaneously in a highly pure crystalline
form. A suﬃcient amount of pure material was produced in
two connected lab-scale tanks for further studies, starting from
an initially small quantity of seeds even though slow growth
kinetics complicated the separations and deviations to the
reported solubility curve were found. This demonstrates the
advantages of the applied quasi-stationary process. Crystal-
lization conditions can be chosen in a way that no or negligible
nucleation of the unseeded enantiomer occurs to keep the
process metastable until a signiﬁcant entrainment of the
preferred enantiomer is visible. An equilibration step during
the preparation procedure of the process decreases the risk of
unexpected dissolution of expensive enantiopure seed material
because of the presence of excess solid racemic material.
Problems arising from inaccurate solubility data or maybe also
as a result of diﬀerent batches of starting racemate can thus be
mitigated.
The solubility of racemic guaifenesin was determined with
an isothermal method while metastable zone width measure-
ments were carried out using polythermal conditions. The
trend of the reported solubility data was veriﬁed, but a small
shift with respect to temperature was found. It was shown that
guaifenesin/water solutions have a rather large zone of
metastability, which increases strongly with faster cooling
rates. Neither a stable nor metastable liquid−liquid demixing
was found during these investigations.
The process was designed rationally on the basis of a few
trial crystallizations, which yielded appropriate operating
conditions for a complete separation. Subsequently, the
operating conditions were adapted, mainly seed loading and
preparation as well as the mass of solid racemic excess material,
to increase yield and productivity. In a ﬁnal experiment, a
maximal productivity of 16.9 g/(kg·h) in the crystallization and
9.1 g/(kg·h) in the dissolution tanks were achieved with
purities exceeding 97%. From all observations of the performed
experiments, maximal productivities, which are mainly based
on an inline turbidity probe, were derived to enhance the
applicability of this process to other systems.
All separation experiments combined in this study yielded
136 g of the (R)-guaifenesin product and 81 g of the (S)-
guaifenesin product with average purities of 88% and 98%,
respectively, starting from only 0.8 g of pure (R)-guaifenesin.
These values were improved to >99.9% by simple recrystalliza-
tion. The lower purity of the (R)-enantiomer results obviously
from primary nucleation of the counter-enantiomer, showing
potential for further improvement of the current process.
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